National Cancer Institute (NCI) purchases Starbridge Hypercomputer® to accelerate genome data research

NewsGuard 100/100 Score
Starbridge Systems announced today that the National Cancer Institute's Advanced Biomedical Computing Center (ABCC) in Frederick, MD, recently purchased a Starbridge Hypercomputer®, the first high-end reconfigurable computer acquired for bioscience research. The Starbridge Hypercomputer will serve as an important scientific computational resource and represents a revolutionary leap in high performance computing capabilities.

Starbridge consulted with Dr. Jack Collins of the National Cancer Institute to assess NCI's research needs, and produced a massively parallel and scalable implementation of the Smith Waterman algorithm, which is used to compare sets of genetic data, on the Starbridge Hypercomputer. Starbridge's implementation of the Smith Waterman algorithm enables NCI to compare genetic data sets of virtually any size in record-breaking time. As part of the final acceptance criteria, Starbridge demonstrated a Smith Waterman comparison of the human X to Y chromosomes. This comparison, which typically requires months of computation time on a cluster, was completed in approximately five days on the Hypercomputer.

"NCI's purchase illustrates the potential for Hypercomputing to accelerate research in the Life Sciences," said Daniel Oswald, President and CEO of Starbridge Systems. "We expect this to be the first of many grand challenge problems solved by Starbridge Hypercomputers."

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
New trials show promise for immune checkpoint blockers in early-stage lung cancer